![Lisa Bollinger](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Lisa Bollinger
Directeur/Bestuurslid bij
APOGEE THERAPEUTICS, INC.
Vermogen: 827 $ op 31-07-2026
Profiel
Lisa L.
Bollinger is currently an Independent Director at Apogee Therapeutics, Inc. since 2024.
Former positions include Associate Director-New Drug at the Center for Drug Evaluation & Research, Vice President-Global Regulatory Affairs, R&D at Amgen, Inc. from 2018 to 2021, VP-Regulatory Affairs & Global Regulatory Affairs at Merck & Co., Inc. from 2021 to 2024, and Chief Medical Officer at Polaryx Therapeutics, Inc. from 2025 to 2026.
Education includes a doctorate from Uniformed Services University of the Health Sciences and an undergraduate degree from the University of California.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 27-07-2026 | 358 ( 0% ) | 827 $ | 31-07-2026 |
Actieve functies van Lisa Bollinger
| Bedrijven | Functie | Begin |
|---|---|---|
| APOGEE THERAPEUTICS, INC. | Directeur/Bestuurslid | 28-05-2024 |
Eerdere bekende functies van Lisa Bollinger
| Bedrijven | Functie | Einde |
|---|---|---|
| POLARYX THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 19-07-2026 |
| MERCK & CO., INC. | Algemeen Adviseur | 01-05-2024 |
| AMGEN INC. | Hoofd Techniek/Wetenschap/O&O | 01-03-2021 |
Center for Drug Evaluation & Research
 Center for Drug Evaluation & Research General GovernmentGovernment Operates agencies for the department of health and human services | Corporate Officer/Principal | - |
Opleiding van Lisa Bollinger
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
73
Eerstegraads connecties
7
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 7 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Uniformed Services University of the Health Sciences
 Uniformed Services University of the Health Sciences Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Center for Drug Evaluation & Research
Center for Drug Evaluation & Research General GovernmentGovernment Operates agencies for the department of health and human services | Government |
University of California
 University of California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Polaryx Therapeutics, Inc.
 Polaryx Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biotechnology company that engages in discovery, development and commercialization of novel, disease-modifying therapies for rare, pediatric lysosomal storage disorders | Commercial Services |
Apogee Therapeutics, Inc.
 Apogee Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develops therapies for immunological and inflammatory disorders | Health Technology |
